Funded by the President's Malaria Initiative (PMI), PQM+ partners with Burma’s Department of Food and Drug Administration (DFDA) to strengthen its medical product quality monitoring system.
The program provides technical assistance to DFDA’s pharmaceutical chemistry laboratories in Nay Pyi Taw and Mandalay to incorporate ISO international accreditation standards, which demonstrate that the laboratories can provide consistently valid results, into regulatory practices.
PQM+ also facilitates a risk-based approach to post-marketing surveillance that helps DFDA better detect substandard and falsified antimalarial medicines on the market, and act accordingly to ensure the quality of malaria commodities in circulation. Concurrently, PQM+ works with private manufacturers to achieve WHO prequalification status for locally manufactured antimalarial medicines in support of the country’s National Malaria Control Program goals to eliminate malaria by 2030.
